President Donald Trump will get legislation on his desk late this year to lower prescription drug prices, Senate Aging Committee Chair Susan Collins predicted today. “The biggest barrier is the complexity of who is making money in the supply chain,” said the Maine Republican. “In 2017, brand name prescription drug prices increased four times faster than inflation. Her remarks came at a Senate Aging hearing where the ranking Democrat, Pennsylvania’s Bob Casey said legislators from his party should seriously consider Trump Administration proposals to lower drug prices. He said he would like to see legislation to let Medicare negotiate drug prices and to allow for the safe importation of drugs.

Source: Forbes March 07, 2019 18:56 UTC